If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

AURA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $15,596,860.00

Insider Selling (Last 12 Months): $59,796.05

Aura Biosciences Insider Trading History Chart

Aura Biosciences Share Price & Price History

^$10.08

▼ -0.4 (-3.82%)

As of 03/22/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Aura Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/5/2023	David Michael Johnson	Director	Buy	396	$10.00	$3,960.00	17,300
12/28/2022	David Michael Johnson	Director	Buy	4,000	$9.75	$39,000.00	17,000
12/5/2022	Matrix Capital Management Comp	Major Shareholder	Buy	1,250,000	$12.00	$15,000,000.00	5,362,870
12/1/2022	David Michael Johnson	Director	Buy	10,000	$12.37	$123,700.00	15,000
10/31/2022	Cadmus Rich	Insider	Sell	1,672	$12.45	$20,816.40	24,578
10/31/2022	Julie B Feder	CFO	Sell	2,015	$12.45	$25,086.75	24,235
10/31/2022	Rosch Mark De	COO	Sell	1,115	$12.46	$13,892.90	16,385
6/13/2022	David Michael Johnson	Director	Buy	20,000	$13.99	$279,800.00	30,000
6/10/2022	David Michael Johnson	Director	Buy	10,000	$15.04	$150,400.00	10,000

The Stock That Is Flying Under Wall St. Radar

From Upexi, Inc | Ad

With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!

SEC Filings (Institutional Ownership Changes) for Aura Biosciences (NASDAQ:AURA)

55.63% of Aura Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aura Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2023	Morgan Stanley	64,603	$0.68M	0.0%	+17.1%	0.220%
2/15/2023	Alps Advisors Inc.	24,432	$0.26M	0.0%	N/A	0.083%
2/15/2023	Nantahala Capital Management LLC	798,751	$8.39M	0.5%	+108.1%	2.723%
2/14/2023	Alyeska Investment Group L.P.	21,456	$0.23M	0.0%	N/A	0.073%
2/14/2023	Price T Rowe Associates Inc. MD	739,215	$7.76M	0.0%	N/A	2.520%
2/14/2023	Water Island Capital LLC	23,500	$0.25M	0.0%	+119.6%	0.080%
2/13/2023	Matrix Capital Management Company LP	5,362,870	$56.31M	1.1%	+30.4%	18.285%
2/13/2023	Barclays PLC	36,519	$0.38M	0.0%	-13.1%	0.125%
2/13/2023	Renaissance Technologies LLC	13,100	$0.14M	0.0%	N/A	0.045%
2/13/2023	The Manufacturers Life Insurance Company	42,585	$0.44M	0.0%	N/A	0.145%
2/13/2023	Geode Capital Management LLC	300,473	$3.15M	0.0%	+3.9%	1.024%
2/13/2023	Artal Group S.A.	410,000	$4.31M	0.2%	N/A	1.398%
2/10/2023	Bank of America Corp DE	27,215	$0.29M	0.0%	-39.8%	0.093%
2/9/2023	Decheng Capital Management III Cayman LLC	293,333	$3.08M	1.2%	+39.7%	1.000%
2/9/2023	Monashee Investment Management LLC	131,640	$1.38M	0.6%	N/A	0.449%
2/9/2023	Citigroup Inc.	145,704	$1.53M	0.0%	-2.7%	0.497%
2/7/2023	TD Asset Management Inc	53,956	$0.57M	0.0%	N/A	0.184%
2/1/2023	Bank of Montreal Can	19,429	$0.27M	0.0%	N/A	0.066%
1/27/2023	Regency Capital Management Inc. DE	554,286	$5.82M	6.7%	+146.8%	1.890%
12/8/2022	Bank of New York Mellon Corp	50,336	$0.91M	0.0%	+25.5%	0.172%
11/16/2022	BNP Paribas Arbitrage SNC	5,821	$0.11M	0.0%	N/A	0.020%
11/15/2022	State Street Corp	298,438	$5.41M	0.0%	+16.2%	1.017%
11/15/2022	Vanguard Group Inc.	605,884	$10.98M	0.0%	+39.2%	2.065%
11/15/2022	Bank of New York Mellon Corp	50,336	$0.91M	0.0%	+25.5%	0.172%
11/15/2022	BlackRock Inc.	1,013,455	$18.36M	0.0%	+14.3%	3.455%
11/14/2022	Water Island Capital LLC	10,700	$0.19M	0.0%	-26.4%	0.037%
11/14/2022	UBS Oconnor LLC	12,430	$0.23M	0.0%	-86.3%	0.042%
11/10/2022	Nantahala Capital Management LLC	383,764	$6.95M	0.5%	+11.8%	1.311%
11/10/2022	UBS Group AG	12,267	$0.22M	0.0%	-24.8%	0.042%
11/4/2022	Regency Capital Management Inc. DE	224,554	$4.07M	5.0%	-11.8%	0.767%
8/23/2022	Captrust Financial Advisors	13,414	$0.19M	0.0%	N/A	0.046%
8/16/2022	Captrust Financial Advisors	13,414	$0.19M	0.0%	N/A	0.046%
8/15/2022	State Street Corp	256,746	$3.64M	0.0%	+202.1%	0.877%
8/15/2022	Nantahala Capital Management LLC	343,215	$4.86M	0.2%	+13.7%	1.173%
8/15/2022	Citadel Advisors LLC	2,312,159	$32.76M	0.0%	-0.2%	7.902%
8/15/2022	Millennium Management LLC	22,917	$0.33M	0.0%	N/A	0.078%
8/13/2022	American International Group Inc.	8,577	$0.12M	0.0%	+208.3%	0.029%
8/12/2022	Northern Trust Corp	132,692	$1.88M	0.0%	+188.0%	0.453%
8/12/2022	FMR LLC	603,471	$8.55M	0.0%	+22.1%	2.062%
8/12/2022	Rhumbline Advisers	20,713	$0.29M	0.0%	N/A	0.071%
8/11/2022	UBS Group AG	16,320	$0.23M	0.0%	+2,064.5%	0.056%
8/11/2022	JPMorgan Chase & Co.	9,798	$0.14M	0.0%	+272.8%	0.033%
8/3/2022	Regency Capital Management Inc. DE	254,622	$3.61M	3.9%	N/A	0.870%
6/7/2022	Bank of America Corp DE	11,857	$0.26M	0.0%	+53.5%	0.041%
5/16/2022	California State Teachers Retirement System	2,358	$52K	0.0%	-21.8%	0.008%
5/16/2022	State Street Corp	84,982	$1.87M	0.0%	+80.1%	0.291%
5/13/2022	Charles Schwab Investment Management Inc.	15,379	$0.34M	0.0%	+30.1%	0.053%
5/13/2022	Nantahala Capital Management LLC	301,990	$6.64M	0.3%	+204.6%	1.034%
5/13/2022	Vanguard Group Inc.	228,633	$5.03M	0.0%	+1.0%	0.782%
5/12/2022	BlackRock Inc.	275,027	$6.05M	0.0%	+15.2%	0.941%
5/11/2022	Bank of New York Mellon Corp	14,496	$0.32M	0.0%	N/A	0.050%
5/11/2022	JPMorgan Chase & Co.	2,628	$58K	0.0%	-60.2%	0.009%
5/10/2022	Decheng Capital Management III Cayman LLC	210,000	$4.62M	1.4%	N/A	0.719%
5/5/2022	New York State Common Retirement Fund	6,252	$0.14M	0.0%	+134.3%	0.021%
2/16/2022	Matrix Capital Management Company LP	4,112,870	$69.84M	0.8%	N/A	14.080%
2/15/2022	Adage Capital Partners GP L.L.C.	1,255,480	$21.32M	0.0%	N/A	4.298%
2/14/2022	Citadel Advisors LLC	2,315,102	$37.32M	0.0%	N/A	7.925%
2/11/2022	Allianz Asset Management GmbH	55,145	$0.94M	0.0%	N/A	0.189%
2/8/2022	Northern Trust Corp	45,875	$0.78M	0.0%	N/A	0.157%
2/3/2022	Medicxi Ventures Management Jersey Ltd	3,039,892	$51.62M	12.9%	N/A	10.407%
2/2/2022	New York State Common Retirement Fund	2,668	$45K	0.0%	N/A	0.009%

Data available starting January 2016

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $10.08

$10.06

$10.79

50 Day Range

MA: $10.51

$9.99

$12.11

52 Week Range

Now: $10.08

$9.43

$24.83

Volume

101,082 shs

Average Volume

114,820 shs

Market Capitalization

$381.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of Aura Biosciences?: Aura Biosciences' top insider investors include:
Matrix Capital Management Comp (Major Shareholder)
David Michael Johnson (Director)
Cadmus Rich (Insider)
Julie B Feder (CFO)
Rosch Mark De (COO)
Learn More about top insider investors at Aura Biosciences.
Who are the major institutional investors of Aura Biosciences?: Aura Biosciences' top institutional investors include:
Matrix Capital Management Company LP — 18.28%
Nantahala Capital Management LLC — 2.72%
Price T Rowe Associates Inc. MD — 2.52%
Regency Capital Management Inc. DE — 1.89%
Artal Group S.A. — 1.40%
Geode Capital Management LLC — 1.02%
Learn More about top institutional investors of Aura Biosciences stock.
Which institutional investors are selling Aura Biosciences stock?: During the previous quarter, AURA stock was sold by these institutional investors:
Bank of America Corp DE
Barclays PLC
Citigroup Inc.
In the last year, company insiders that have sold Aura Biosciences company stock include:
Matrix Capital Management Comp (Major Shareholder)
David Michael Johnson (Director)
Cadmus Rich (Insider)
Learn More investors selling Aura Biosciences stock.
Which institutional investors are buying Aura Biosciences stock?: During the last quarter, AURA stock was acquired by institutional investors including:
Matrix Capital Management Company LP
Price T Rowe Associates Inc. MD
Nantahala Capital Management LLC
Artal Group S.A.
Regency Capital Management Inc. DE
Monashee Investment Management LLC
Decheng Capital Management III Cayman LLC
TD Asset Management Inc
During the previous year, these company insiders have bought Aura Biosciences stock:
Matrix Capital Management Comp (Major Shareholder)
David Michael Johnson (Director)
Learn More investors buying Aura Biosciences stock.